Paul W. Huber

Array ( [id] => 5827954 [patent_doc_number] => 20020068072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'USE OF A SUBSTANCE P ANTAGONIST IN A PHARMACEUTICAL COMPOSITION' [patent_app_type] => new [patent_app_number] => 08/921524 [patent_app_country] => US [patent_app_date] => 1997-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3008 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068072.pdf [firstpage_image] =>[orig_patent_app_number] => 08921524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435634 [patent_doc_number] => 06355276 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Adhesive drug delivery composition' [patent_app_type] => B1 [patent_app_number] => 08/234723 [patent_app_country] => US [patent_app_date] => 1994-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3048 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355276.pdf [firstpage_image] =>[orig_patent_app_number] => 08234723 [rel_patent_id] =>[rel_patent_doc_number] =>)